1383472-41-0

Upstream product

• 1383475-09-9 1-(3-(trifluoromethyl)benzyl)-1H-indazol-4-amine 
• 1383475-08-8 3-iodo-4-nitro-1-(3-(trifluoromethyl)benzyl)-1H-indazole 
• 1313408-94-4 7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester 
• 1383475-13-5 5-chloro-1-(3-(trifluoromethyl)benzyl)-1H-indazol-4-amine 
• 1313408-96-6 7-dimethylcarbamoyl-imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester 
• 885521-22-2 3-iodo-4-nitro-1H-indazole 
• 2942-40-7 nitro-4 indazole 
• 5464-12-0 2-(4-methylpiperazinyl)ethanol 

Relevant academic research and scientific papers

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS

Compounds of Formula I: and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal